Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma

Cancer Communications(2024)10.1002/cac2.12620Source: DataRank Database

Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma is a research paper published in Cancer Communications (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.82)OA: goldTopics (18)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Sreenidhi Mohanvelu,Dinesh Babu Somasundaram ORCID,Sivaroopan Aravindan ORCID,Natarajan Aravindan ORCID,Poorvi Subramanian

Live enrichment

PubMed:39445727 OpenAlex:https://openalex.org/W4403704107

U.S. Department of Defense

Grant: DoD CA‐210339

Oklahoma Center for the Advancement of Science and Technology

Grant: HR19‐045

National Institutes of Health

Grant: P20GM103639

Oklahoma Tobacco Settlement Endowment Trust

Grant: R23‐03

National Institutes of Health

Grant: 5P20GM103639-08

Mentoring Translational Cancer Research in Oklahoma

National Institutes of Health

Grant: 3P30CA225520-06S4

Stephenson Cancer Center - Cancer Center Support Grant

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cac2.12620

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cac2.12620

publisherhttps://spj.science.org/doi/pdf/10.1002/cac2.12620

journalhttps://doi.org/10.1002/cac2.12620

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39445727

Fields of Study

Neuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismLung Cancer Research Studies03 medical and health sciences0302 clinical medicine

Keywords

NeuroblastomaImmune surveillanceImmune systemMedicineNeuroscienceOncologyPsychologyImmunologyBiologyGeneticsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Letter to the Journal

Sustainable Development Goals

SDG 0: Good health and well-being